Evidence map›Paper›PMID 39892407›Full record

Observational studyLancet (London, England)2025

Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu, Democratic Republic of the Congo: a prospective cohort study.

Isabel Brosius, Emmanuel Hasivirwe Vakaniaki, Guy Mukari, Papy Munganga, Jean Claude Tshomba, Elise De Vos, Eugene Bangwen, Yves Mujula, Achilleas Tsoumanis, Christophe Van Dijck and 30 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Lancet (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06840860 (Monkeypox Biology, Outcome, Transmission and Epidemiology), which is not on this map. Cited by 58 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06840860 recruitingnot on this map

Monkeypox Biology, Outcome, Transmission and Epidemiology (MBOTE) Study: Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)

Typeobservational_patient_registrySponsorInstitute of Tropical Medicine, BelgiumRan2025 to 2027Enrolled1,000ConditionsMonkeypox (Mpox)
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Observational
  13. Review
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors.

Isabel BrosiusDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Emmanuel Hasivirwe VakaniakiDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Guy MukariDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Papy MungangaDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Jean Claude TshombaRodolphe Mérieux Institut National de Recherche Biomédicale, Goma Laboratory, Goma, Democratic Republic of the Congo.
Elise De VosDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Eugene BangwenDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Yves MujulaInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Achilleas TsoumanisDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Christophe Van DijckDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Aimé AlengoDivision Provinciale de la Santé, South Kivu, Democratic Republic of the Congo.
Léandre Mutimbwa-MamboKamituga Health Zone, South Kivu, Democratic Republic of the Congo.
Franklin Mweshi KumbanaKamituga General Hospital, South Kivu, Democratic Republic of the Congo.
Jenestin Babingwa MungaKamituga General Hospital, South Kivu, Democratic Republic of the Congo.
Divin Mazambi MamboKamituga General Hospital, South Kivu, Democratic Republic of the Congo.
James Wakilongo ZangilwaKamituga General Hospital, South Kivu, Democratic Republic of the Congo.
Steeven Bilembo KitwandaKamituga General Hospital, South Kivu, Democratic Republic of the Congo.
Sarah HoubenDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Nicole A HoffDepartment of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA, USA.
Jean-Claude Makangara-CigoloInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo; Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Eddy Kinganda-LusamakiInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo; TransVIHMI (Recherches Translationnelles sur le VIH et les Maladies Infectieuses), Université de Montpellier, Institut de Recherche pour le Développement (IRD), Institut National de Santé et de Recherche Médicale (INSERM), Montpellier, France.
Martine PeetersTransVIHMI (Recherches Translationnelles sur le VIH et les Maladies Infectieuses), Université de Montpellier, Institut de Recherche pour le Développement (IRD), Institut National de Santé et de Recherche Médicale (INSERM), Montpellier, France.
Anne W RimoinDepartment of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA, USA.
Jason KindrachukDepartment of Medical Microbiology & Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.
Nicola LowInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Patrick D M C KatotoCenter for Tropical Diseases and Global Health, Catholic University of Bukavu, Bukavu, Democratic Republic of the Congo; Cochrane South Africa, Medical Research Council of South Africa, Division of Epidemiology and Biostatics, Department of Global Health, Faculty of Medicine, Stellenbosch University, South Africa.
Espoir Bwenge MalembakaCenter for Tropical Diseases and Global Health, Catholic University of Bukavu, Bukavu, Democratic Republic of the Congo; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
John H AmuasiGlobal Health and Infectious Diseases Research Group, Kumasi Center for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; Research Group Global One Health, Department of Implementation Research, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Olivier Tshiani-MbayaInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Dally Muamba KambajiThe Alliance for International Medical Action, Goma, Democratic Republic of the Congo.
Richard KojanThe Alliance for International Medical Action, Goma, Democratic Republic of the Congo.
Cris KacitaNational Program for Monkeypox and Viral Hemorrhagic Fevers, Ministry of Health, Kinshasa, Democratic Republic of the Congo.
Daniel Mukadi-BamulekaInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo; Rodolphe Mérieux Institut National de Recherche Biomédicale, Goma Laboratory, Goma, Democratic Republic of the Congo; Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Steve Ahuka-MundekeInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo; Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Koen VercauterenDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Tony Wawina-BokalangaDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo; Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Jean-Jacques Muyembe-TamfumInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo; Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Sabin Sabiti NunduDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Laurens LiesenborghsDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium. Electronic address: lliesenborghs@itg.be.
Placide Mbala-KingebeniInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo; Service de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo. Electronic address: placide.mbala@inrb.cd.

Funding

European & Developing Countries Clinical Trials Partnership (EDCTP) RIA2016E-1612
6 · The paper itself

Abstract

backgroundClade Ib, a new strain of clade I monkeypox virus, emerged in eastern DR Congo, sparking an international outbreak. Comprehensive studies are needed to assess its transmission dynamics and clinical presentation.

methodsWe did a prospective observational cohort study at Kamituga General Hospital in South Kivu, DR Congo, between May 2 and Oct 9, 2024. Sociodemographic, exposure, and clinical data were collected from mpox-suspected cases. Cases were confirmed by Xpert Mpox PCR and followed through hospitalisation and on days 29 and 59 after diagnosis.

findingsOf the 510 suspected cases included, 407 (80%) tested positive via PCR. Among the 407 confirmed cases, 196 (48%) were women. Age distribution was bimodal, with 58 (14%) children younger than 5 years, and 267 (66%) individuals aged 15-34 years. Most cases (237 [58%] of 406) reported contact with a suspected or confirmed mpox case; primarily colleagues, spouses or sexual partners in adults, and parents or siblings in children. Self-reported comorbidities were rare (18 [5%] of 400), including 6 (2%) people infected with HIV. Prodromal symptoms were present in 331 (88%) of 375 patients, active skin lesions in 394 (97%) of 407 patients, mucosal lesions in 324 (82%) of 394 patients, and lymphadenopathy in 288 (73%) of 394 patients. In adults, 280 (89%) of 314 had genital skin lesions and mean lesion density was highest in the genital area. In contrast, only 35 (42%) of 84 children had genital lesions, as part of a more uniform rash. Among 403 hospitalised patients, two (<1%) deaths occurred. Among 296 patients with detailed hospital follow-up, complications were primarily genito-urinary (169 [57%]) or cutaneous (121 [41%]). Four (67%) of six pregnant women with recorded outcome had adverse pregnancy outcomes. On days 29 and 59, few sequelae were reported other than scars.

interpretationClade Ib infections in Kamituga showed distinct clinical patterns compared with clade Ia outbreaks elsewhere in the country and the global clade IIb outbreak. In adults, the disease primarily affected the genito-urinary system, compatible with sexual transmission, whereas children mostly manifested extragenital lesions. These findings highlight the need for updated case definitions and targeted public health interventions to address evolving transmission dynamics and mitigate risks for vulnerable groups, including pregnant women and young children.

fundingEuropean & Developing Countries Clinical Trials Partnership (EDCTP2 and EDCTP3); Belgian Directorate-General Development Cooperation and Humanitarian Aid; Research Foundation-Flanders.

Indexed as

Disease OutbreaksMonkeypox virusMpox, MonkeypoxAdolescentAdultChildChild, PreschoolDemocratic Republic of the CongoFemaleHumansInfantMaleMiddle AgedPregnancyProspective StudiesYoung Adult

Identifiers

PMID39892407
PMCPMC7618259

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.